Xenetic Biosciences Inc Total Liabilities

Latest as of June 2026: $894.98K USD

Xenetic Biosciences Inc total liabilities. Based on the latest financial reports, Xenetic Biosciences Inc (XBIO) has total liabilities worth $894.98K USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check XBIO asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Xenetic Biosciences Inc (2011–2025)

Total liabilities of Xenetic Biosciences Inc from 2011 to 2025. This chart illustrates how Xenetic Biosciences Inc's total liabilities have evolved over time, based on quarterly financial data.

Xenetic Biosciences Inc Competitors by Total Liabilities

The table below lists competitors of Xenetic Biosciences Inc ranked by their total liabilities.

Company	Country	Total Liabilities
MEKICS Co Ltd KQ:058110	Korea	₩19.37 Billion
Samchai Steel Industries Public Company Limited BK:SAM	Thailand	฿2.41 Billion
Altur Slatina RO:ALT	Romania	RON52.21 Million
Intan Baruprana Finance Tbk JK:IBFN	Indonesia	Rp1.27 Trillion
Altheora SA PA:ALORA	France	€23.25 Million
Astrotech Corp NASDAQ:ASTC	USA	$4.18 Million
Gasporox AB (publ) ST:GPX	Sweden	Skr29.19 Million
Manas Enerji Yonetimi Sanayi & Ticaret AS IS:MANAS	Turkey	TL624.23 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Xenetic Biosciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see XBIO current and non-current assets.

Liquidity & Leverage Metrics

Xenetic Biosciences Inc Total Liabilities Ratios Explained

Xenetic Biosciences Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	7.43	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.15	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.13	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Xenetic Biosciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Xenetic Biosciences Inc (2011–2025)

The table below shows the annual total liabilities of Xenetic Biosciences Inc from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	$968.02K	+8.25%
2024-12-31	$894.26K	+10.46%
2023-12-31	$809.59K	-24.56%
2022-12-31	$1.07 Million	-24.48%
2021-12-31	$1.42 Million	+47.42%
2020-12-31	$963.97K	-77.76%
2019-12-31	$4.33 Million	-4.09%
2018-12-31	$4.52 Million	-7.07%
2017-12-31	$4.86 Million	+1.20%
2016-12-31	$4.80 Million	-53.35%
2015-12-31	$10.30 Million	+76.50%
2014-12-31	$5.84 Million	-14.79%
2013-12-31	$6.85 Million	+49.11%
2012-12-31	$4.59 Million	+1980.58%
2011-12-31	$220.74K	--

About Xenetic Biosciences Inc

NASDAQ:XBIO USA Biotechnology

Market Cap

$4.87 Million

Market Cap Rank

#28567 Global

#5875 in USA

Share Price

$2.08

Change (1 day)

+0.97%

52-Week Range

$1.72 - $4.67

All Time High

$3642.84